Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

94 CARBAMAZEPINE
Nails – lichen planus
(1989): Ohtsuyama M+, Nishinihon J Dermatol (Japanese)
51, 958
Nails – loss
(1982): Breathnach SM+, Clin Exp Dermatol 7, 585
Nails – onychomadesis
(1989): Mishra D+, Int J Dermatol 28, 460
Eyes
Dyschromatopsia
(2000): Nousiainen I+, Ophthalmology 107, 884
Periorbital edema
(2001): Dintiman B, Fairfax, VA (from Internet) (observation)
Visual hallucinations
(2006): Beitinger PA+, Pharmacopsychiatry 39(5), 192
Other
Anticonvulsant hypersensitivity syndrome
(2006): Beitinger PA+, Pharmacopsychiatry 39(5), 192
(2006): Matsuda K+, Prog Neuropsychopharmacol Biol Psychiatry
30(4), 751
(2006): So JS+, Dermatology 213(2), 166
(2005): Hara H+, Dermatology 211(2), 159
(2004): Duran-Ferreras E+, Rev Neurol 38(12), 1136
(2004): Ogihara T+, J Clin Psychopharmacol 24(1), 105
(2004): Papp Z+, Orv Hetil 145(32), 1665
(2003): Bin-Nakhi HA+, Med Princ Pract 12(3), 197
(2002): Galindo PA+, J Investig Allergol Clin Immunol 12(4), 299
(2002): Kaur S+, Pediatr Dermatol 19(2), 142
(2002): Metin A+, World Congress Dermatol Poster, 0116
(2002): Romero Maldonado N+, Eur J Dermatol 12(5), 503
(2000): Moore, SJ+, JMedGenet37, 489
(2000): Popescu C, Bucharest, Romania (from Internet)
(observation)
(1997): Morkunas AR+, Crit Care Clin 13(4), 727
(1995): Vittorio CC+, Arch Intern Med 155(21), 2285
Death
(2006): Skopp G+, Arch Kriminol 217(5-6), 161 (with
levetiracetam)
(2002): Correia O+, Arch Dermatol 138, 29
DRESS syndrome
(2006): Kim CW+, J Korean Med Sci 21(4), 768
(2006): Yun SJ+, Acta Derm Venereol 86(3), 241 (with valproic
acid)
(2005): Syn WK+, Int J Clin Pract 59(8), 988
(2004): Allam JP+, Eur J Dermatol 14(5), 339
(2004): Valencak J+, Int J Dermatol 43(1), 51
(2002): Maradeix S+, World Congress Dermatol Poster, 0112
(2001): Descamps V+, Arch Dermatol 137, 301 (5 patients)
(2001): Queyrel V+, Rev Med Interne 22(6), 582
Fetal hydantoin syndrome
(2000): Moore SJ+, JMedGenet37, 489
Hepatotoxicity
(2006): Skopp G+, Arch Kriminol 217(5-6), 161 (with
levetiracetam)
(1999): Morales-Diaz M+, Pharmacotherapy 19(2), 252
(1993): Martinez P+, Rev Esp Enferm Dig 84(2), 124
(1989): Rodriguez Hernandez H+, Rev Gastroenterol Mex
54(4), 239
Hypersensitivity
(2006): Alfirevic A+, Pharmacogenet Genomics 16(4), 287
(2006): Beitinger PA+, Pharmacopsychiatry 39(5), 192
(2006): Hung SI+, Pharmacogenet Genomics 16(4), 297
(2006): Matsuda K+, Prog Neuropsychopharmacol Biol Psychiatry
30(4), 751
(2006): Seitz CS+, Ann Allergy Asthma Immunol 97(5), 698
(2005): Laad G+, Indian J Dermatol Venereol Leprol 71(1), 35
(2003): Aihara Y+, Br J Dermatol 149(1), 165
(2003): Feliciani C+, Int J Immunopathol Pharmacol 16(1), 89
(2002): Kaur S+, Pediatr Dermatol 19(2), 142
(2001): Bessmertny O+, Ann Pharmacother 35(5), 533
(2001): Miranda-Romero A+, Cutis 67(1), 47
(2001): Nashed MH+, Pharmacotherapy 21(4), 502
(2001): Sekine N+, JAMA 285(9), 1153
(2000): Bugatti L, Italy (from Internet) (observation)
(2000): Elstner S+, Fortschr Neurol Psychiatr (German) 68, 188
(2000): Ivry S+, Harefuah (Hebrew) 138, 545
(2000): Straussberg R+, Pediatr Neurol 22, 231
(2000): Verrotti A+, Int J Immunopathol Pharmacol 13(1), 49
(1999): Balasubrananian S+, Indian Pediatr 36, 98
(1999): Brown KL+, Dev Med Child Neurol 41, 267
(1999): Eland IA+, Epilepsia 40(12), 1780
(1999): Hamer HM+, Seizure 8, 190
(1999): Lombardi SM+, Ann Pharmacother 33, 571
(1999): Mesec A+, J Neurol Neurosurg Psychiatry 66, 249
(1999): Moss DM+, J Emerg Med 17, 503
(1999): Ronsdorf A+, Schweiz Rundsch Med Prax 88(41), 1660
(1998): Dertinger S+, JHepatol28, 356
(1998): Schlienger RG+, Epilepsia 39, S3 (passim)
(1997): Morkunas AR+, Crit Care Clin 13, 727
(1997): Pichler WJ+, New Engl J Med 336, 377
(1997): Stein J+, Dtsch Med Wochenschr (German) 122, 314
(1997): Tennis P+, Neurology 49, 542
(1997): Waagner DC, New Engl J Med 336, 376
(1996): New Engl J Med 335, 577
(1996): Callot V+, Arch Dermatol 132, 1315
(1996): Knowles SR+, J Clin Psychopharmacol 16, 263
(1996): Koopman R, Enschede, The Netherlands (from Internet)
(observation)
(1996): Oakley A, Hamilton, New Zealand (from Internet)
(observation)
(1995): Bellman B+, J Am Acad Child Adolesc Psychiatry 34, 1405
(1995): De Vriese AS+, Medicine Baltimore 74, 144
(1995): Periole B+, Ann Dermatol Venereol 122, 121
(1994): Alldredge BK+, Pediatr Neurol 10, 169
(1994): Gall H+, Hautarzt (German) 45, 494
(1994): Naranjo CA+, Clin Pharmacol Ther 56, 564
(1993): Handfield-Jones SE+, Br J Dermatol 129, 175
(1993): Parha S+, Eur J Pediatr 152, 1040
(1993): Scerri L+, Clin Exp Dermatol 18, 540
(1991): Baguena F+, Med Clin (Barc) (Spanish) 96, 237
(1991): Hosoda N+, Arch Dis Child 66, 722
(1989): Malanin G+, Duodecim (Finnish) 105, 784
(1983): Bernstein DI+, Clin Pediatr (Phila) 22, 524
Inappropriate secretion of antidiuretic hormone (SIADH)
(2005): Llinares-Tello F+, Rev Neurol 40(12), 768
(2001): Novakovic M+, Psychiatr Prax 28(1), 48
(1999): Inamura T+, No Shinkei Geka 27(1), 85
(1998): Perez-Camarero E+, Rev Neurol 27(157), 522
(1995): Boutros NN+, J Clin Psychiatry 56(8), 377
(1994): Van Amelsvoort T+, Epilepsia 35(1), 181
(1993): Atalay S+, Jpn Heart J 34(2), 239
(1992): Steelman R+, Spec Care Dentist 12(2), 79
(1990): Cooney JA, Am J Psychiatry 147(8), 1101
(1990): Emsley RA+, SAfrMedJ77(6), 307
(1989): Khan A+, Am J Psychiatry 146(12), 1639
(1985): Carranco E+, Arch Neurol 42(2), 187 (with
erythromycin)
(1984): Appleby L, J Neurol Neurosurg Psychiatry 47(10), 1138
Lymphoproliferative disease
(1992): Schlaifer D+, Eur J Dermatol 48, 274
(1992): Sigal-Nahum M+, Br J Dermatol 127, 545
(1990): Katzin WE+, Arch Pathol Lab Med 114, 1244
(1987): Severson GS+, Am J Med 83, 597
(1984): Shuttleworth D+, Clin Exp Dermatol 9, 421
Nephrotoxicity
(2001): Mayan H+, Ann Pharmacother 35(5), 560
(1997): Eijgenraam JW+, Neth J Med 50(1), 25
Porphyria cutanea tarda
(1996): Leo RJ+, Am J Psychiatry 153, 443